Finally, a significant drug main effect ( p = 0.01) was found for total ghrelin, showing that blood total ghrelin concentrations during the oral cannabis session were higher than the smoked and vaporized cannabis sessions (Fig
reported that [Ser (2) exendin (1-9)], a GLP-1R agonist, significantly attenuated kainic acid-induced apoptosis in the CA3 region of the hippocampus (193)
The proposal would require medical spas to register with the state, undergo inspections, designate a responsible licensed practitioner, and report serious adverse events, while tightening pharmacy compliance with federal standards
2.4% placebo) 86.4% of participants lost at least 5% of body weight 69.1% lost at least 10% 50.5% lost at least 15% STEP 3 (Wadden et al., 2021, JAMA ): Combined with intensive behavioral therapy Average weight loss: 16.0% over 68 weeks Demonstrated that lifestyle support amplifies medication effects STEP 5 (Garvey et al., 2022, Nature Medicine ): Two-year duration study Average weight loss: 15.2% maintained over 104 weeks Demonstrated sustained effectiveness with continued use Retatrutide Clinical Trial Results Phase 2 Trial (Jastreboff et al., 2023, NEJM ): 338 adults with obesity (BMI 30+) or overweight (BMI 27+) with comorbidities Multiple dose groups (1 mg, 4 mg, 8 mg, 12 mg weekly) Results at the 12 mg dose: Average weight loss: 24.2% in 48 weeks 100% of participants lost at least 5% of body weight 93% lost at least 10% 83% lost at least 15% 63% lost at least 20% Weight loss trajectory had not plateaued at study end Comprehensive Comparison Table Side Effects Comparison Both medications share similar gastrointestinal side effect profiles because they both activate GLP-1 receptors
